APREA THERAPEUTICS INC's ticker is APRE and the CUSIP is 03836J102. A total of 64 filers reported holding APREA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $6,437,000 | +4.7% | 1,259,662 | 0.0% | 2.66% | +30.8% |
Q2 2021 | $6,147,000 | -4.3% | 1,259,662 | 0.0% | 2.04% | +62.7% |
Q1 2021 | $6,424,000 | -8.5% | 1,259,662 | -11.7% | 1.25% | +71.7% |
Q4 2020 | $7,018,000 | -84.3% | 1,426,328 | -23.1% | 0.73% | -91.1% |
Q3 2020 | $44,613,000 | -99.9% | 1,854,229 | 0.0% | 8.16% | -21.0% |
Q2 2020 | $71,907,001,000 | – | 1,854,229 | – | 10.33% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
5AM Venture Management, LLC | 1,377,654 | $6,778,000 | 2.28% |
Versant Venture Management, LLC | 1,426,328 | $7,018,000 | 0.73% |
COASTAL INVESTMENT MANAGEMENT, L.P. | 41,965 | $206,000 | 0.38% |
Redmile Group, LLC | 1,268,718 | $6,242,000 | 0.08% |
Gyon Technologies Capital Management, LP | 41,801 | $206,000 | 0.07% |
SECTORAL ASSET MANAGEMENT INC | 163,681 | $805,000 | 0.06% |
Palo Alto Investors LP | 128,770 | $634,000 | 0.03% |
Walleye Capital LLC | 100,800 | $496,000 | 0.03% |
Virtus ETF Advisers LLC | 10,261 | $50,000 | 0.02% |
Candriam S.C.A. | 362,346 | $1,783,000 | 0.01% |